120
Participants
Start Date
May 31, 2013
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Dexmedetomidine
Infusion of dexmedetomidine (0.4 ug/kg/hr)
Sevoflurane
Control Vol% to maintain BIS 40\~45
Propofol and Remifentanil
Control effect site concentration for maintain BIS 40\~45 and changes of vital signs within 20%.
Normal saline
Use as placebo
Rocuronium
0.8 mg/kg for induction
Chosun University Hospital, Gwangju
Chosun University Hospital
OTHER